1921
Volume 99, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

There is increasing interest in using dried blood spot (DBS) cards to extend the reach of global health and disease surveillance programs to hard-to-reach populations. Conceptually, DBS offers a cost-effective solution for multiple use cases by simplifying logistics for collecting, preserving, and transporting blood specimens in settings with minimal infrastructure. This review describes methods to determine both the reliability of DBS-based bioanalysis for a defined use case and the optimal conditions that minimize pre-analytical sources of data variability. Examples by the newborn screening, drug development, and global health communities are provided in this review of published literature. Sources of variability are linked in most cases, emphasizing the importance of field-to-laboratory standard operating procedures that are evidence based and consider both stability and efficiency of recovery for a specified analyte in defining the type of DBS card, accessories, handling procedures, and storage conditions. Also included in this review are reports where DBS was determined to not be feasible because of technology limitations or physiological properties of a targeted analyte.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.17-0889
2018-08-02
2018-10-23
Loading full text...

Full text loading...

/deliver/fulltext/14761645/99/2/tpmd170889.html?itemId=/content/journals/10.4269/ajtmh.17-0889&mimeType=html&fmt=ahah

References

  1. Clinical and Laboratory Standards Institute, 2017. GP41: Collection of Diagnostic Venous Blood Specimens. Wayne, PA: Clinical and Laboratory Standards Institute.
  2. Lim MD, Dickherber A, Compton CC, , 2011. Before you analyze a human specimen, think quality, variability, and bias. Anal Chem 83: 813.
  3. Fonjungo PN, Alemnji GA, Kebede Y, Opio A, Mwangi C, Spira TJ, Beard RS, Nkengasong JN, , 2017. Combatting global infectious diseases: a network effect of specimen referral systems. Clin Infect Dis 64: 796803.
  4. Smit PW, Elliott I, Peeling RW, Mabey D, Newton PN, , 2014. An overview of the clinical use of filter paper in the diagnosis of tropical diseases. Am J Trop Med Hyg 90: 195210.
  5. Benyshek DC, , 2010. Use of dried blood spots: an ideal tool for medical anthropology “in the field”. J Diabetes Sci Technol 4: 255257.
  6. Stove CP, Ingels A-SME, De Kesel PMM, Lambert WE, , 2012. Dried blood spots in toxicology: from the cradle to the grave? Crit Rev Toxicol 42: 230243.
  7. Martial LC, Aarnoutse RE, Schreuder MF, Henriet SS, Brüggemann RJM, Joore MA, , 2016. Cost evaluation of dried blood spot home sampling as compared to conventional sampling for therapeutic drug monitoring in children. PLoS One 11: e0167433.
  8. Mössner BK, Staugaard B, Jensen J, Lillevang ST, Christensen PB, Holm DK, , 2016. Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life. World J Gastroenterol 22: 76047612.
  9. Centers for Disease Control and Prevention, 2017. Shipping Guidelines for Dried-Blood Spot Specimens. Available at: https://www.cdc.gov/labstandards/nsqap_resources.html. Accessed February 1, 2018.
  10. van Loo IHM, Dukers-Muijrers NHTM, Heuts R, van der Sande MAB, Hoebe CJPA, , 2017. Screening for HIV, hepatitis B and syphilis on dried blood spots: a promising method to better reach hidden high-risk populations with self-collected sampling. PLoS One 12: e0186722.
  11. Soulier A, Poiteau L, Rosa I, Hézode C, Roudot-Thoraval F, Pawlotsky J-M, Chevaliez S, , 2016. Dried blood spots: a tool to ensure broad access to hepatitis C screening, diagnosis, and treatment monitoring. J Infect Dis 213: 10871095.
  12. Wagner M, Tonoli D, Varesio E, Hopfgartner G, , 2016. The use of mass spectrometry to analyze dried blood spots. Mass Spectrom Rev 35: 361438.
  13. Li W, Lee MS, , eds., 2014. Dried Blood Spots: Applications and Techniques. Hoboken, NJ: John Wiley & Sons, Inc.
  14. McDade TW, , 2014. Development and validation of assay protocols for use with dried blood spot samples. Am J Hum Biol 26: 19.
  15. Grüner N, Stambouli O, Ross RS, , 2015. Dried blood spots–preparing and processing for use in immunoassays and in molecular techniques. J Vis Exp 97: e52619.
  16. World Health Organization, 2012. WHO Manual for HIV Drug Resistance Testing Using Dried Blood Spot Specimens. Available at: http://www.who.int/hiv/pub/drugresistance/dried_blood_spots/en/. Accessed February 1, 2018.
  17. Zakaria R, Allen KJ, Koplin JJ, Roche P, Greaves RF, , 2016. Advantages and challenges of dried blood spot analysis by mass spectrometry across the total testing process. EJIFCC 27: 288317.
  18. Jager NGL, Rosing H, Schellens JHM, Beijnen JH, , 2014. Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review. Bioanalysis 6: 24812514.
  19. Guthrie R, Susi A, , 1963. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32: 338343.
  20. World Health Organization, 2005. Module 14: Blood Collection and Handling—Dried Blood Spot (DBS). Available at: http://www.who.int/diagnostics_laboratory/documents/guidance/pm_module14.pdf. Accessed February 1, 2018.
  21. Murphy SC, Daza G, Chang M, Coombs R, , 2012. Laser cutting eliminates nucleic acid cross-contamination in dried-blood-spot processing. J Clin Microbiol 50: 41284130.
  22. Li F, Ploch S, Fast D, Michael S, , 2012. Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection. J Mass Spectrom 47: 655667.
  23. Mitchell C, Kraft K, Peterson D, Frenkel L, , 2010. Cross-contamination during processing of dried blood spots used for rapid diagnosis of HIV-1 infection of infants is rare and avoidable. J Virol Methods 163: 489491.
  24. Cordovado SK, Earley MC, Hendrix M, Driscoll-Dunn R, Glass M, Mueller PW, Hannon WH, , 2009. Assessment of DNA contamination from dried blood spots and determination of DNA yield and function using archival newborn dried blood spots. Clin Chim Acta 402: 107113.
  25. Mak CM, Lee H-CH, Chan AY-W, Lam C-W, , 2013. Inborn errors of metabolism and expanded newborn screening: review and update. Crit Rev Clin Lab Sci 50: 142162.
  26. Dube Q, Dow A, Chirambo C, Lebov J, Tenthani L, Moore M, Heyderman RS, Van Rie A, CHIDEV study Team, 2012. Implementing early infant diagnosis of HIV infection at the primary care level: experiences and challenges in Malawi. Bull World Health Organ 90: 699704.
  27. Smit PW, 2014. Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS One 9: e86461.
  28. Govender K, Parboosing R, Siyaca N, Moodley P, , 2016. Dried blood spot specimen quality and validation of a new pre-analytical processing method for qualitative HIV-1 PCR, KwaZulu-Natal, South Africa. Afr J Lab Med 5: 349.
  29. Gakhar H, Holodniy M, , 2014. Use of dried blood spot samples in HCV-, HBV-, and influenza-related epidemiological studies. Li W, Lee MS, eds. Dried Blood Spots. Hoboken, NJ: John Wiley & Sons, Inc., 95113.
  30. Taneja I, Erukala M, Raju KSR, Singh SP, Wahajuddin, 2013. Dried blood spots in bioanalysis of antimalarials: relevance and challenges in quantitative assessment of antimalarial drugs. Bioanalysis 5: 21712186.
  31. Färnert A, Arez AP, Correia AT, Björkman A, Snounou G, do Rosário V, , 1999. Sampling and storage of blood and the detection of malaria parasites by polymerase chain reaction. Trans R Soc Trop Med Hyg 93: 5053.
  32. Clinical and Laboratory Standards Institute, 2013. Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard—Sixth Edition, NBS01A6E. 6th edition. Wayne, PA: Clinical and Laboratory Standards Institute.
  33. George RS, Moat SJ, , 2016. Effect of dried blood spot quality on newborn screening analyte concentrations and recommendations for minimum acceptance criteria for sample analysis. Clin Chem 62: 466475.
  34. World Health Organization, 2010. 7, Capillary Sampling. Guidelines on Drawing Blood: Best Practices in Phlebotomy. Geneva, Switzerland: WHO. Available at: https://www.ncbi.nlm.nih.gov/books/NBK138654/. Accessed May 1, 2018.
  35. Monleau M, et al.; ANRS 12235 Study Group, 2014. Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia. J Clin Microbiol 52: 578586.
  36. Monleau M, Montavon C, Laurent C, Segondy M, Montes B, Delaporte E, Boillot F, Peeters M, , 2009. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing. J Clin Microbiol 47: 11071118.
  37. Zida S, 2016. Estimation of HIV-1 DNA level interfering with reliability of HIV-1 RNA quantification performed on dried blood spots collected from successfully treated patients. J Clin Microbiol 54: 16411643.
  38. Sawadogo S, Shiningavamwe A, Chang J, Maher AD, Zhang G, Yang C, Gaeb E, Kaura H, Ellenberger D, Lowrance DW, , 2014. Limited utility of dried-blood- and plasma spot-based screening for antiretroviral treatment failure with Cobas Ampliprep/TaqMan HIV-1 version 2.0. J Clin Microbiol 52: 38783883.
  39. Chang J, 2017. Performance characteristics of finger-stick dried blood spots (DBS) on the determination of human immunodeficiency virus (HIV) treatment failure in a pediatric population in Mozambique. PLoS One 12: e0181054.
  40. Schmitz ME, et al.; for VL-DBS Study Group, 2017. Field evaluation of dried blood spots for HIV-1 viral load monitoring in adults and children receiving antiretroviral treatment in Kenya: implications for scale-up in resource-limited settings. J Acquir Immune Defic Syndr 74: 399406.
  41. Baidjoe A, 2013. Combined DNA extraction and antibody elution from filter papers for the assessment of malaria transmission intensity in epidemiological studies. Malar J 12: 272.
  42. Burnett JE, , 2011. Dried blood spot sampling: practical considerations and recommendation for use with preclinical studies. Bioanalysis 3: 10991107.
  43. Cobb Z, 2013. In-depth study of homogeneity in DBS using two different techniques: results from the EBF DBS-microsampling consortium. Bioanalysis 5: 21612169.
  44. Caron A, Lelong C, Pascual M-H, Benning V, , 2015. Miniaturized blood sampling techniques to benefit reduction in mice and refinement in nonhuman primates: applications to bioanalysis in toxicity studies with antibody-drug conjugates. J Am Assoc Lab Anim Sci 54: 145152.
  45. Spooner N, Lad R, Barfield M, , 2009. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal Chem 81: 15571563.
  46. Chapman K, Chivers S, Gliddon D, Mitchell D, Robinson S, Sangster T, Sparrow S, Spooner N, Wilson A, , 2014. Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies. Drug Discov Today 19: 528532.
  47. Nilsson LB, Ahnoff M, Jonsson O, , 2013. Capillary microsampling in the regulatory environment: validation and use of bioanalytical capillary microsampling methods. Bioanalysis 5: 731738.
  48. Amara AB, Else LJ, Carey D, Khoo S, Back DJ, Amin J, Emery S, Puls RL, , 2017. Comparison of dried blood spots versus conventional plasma collection for the characterization of efavirenz pharmacokinetics in a large-scale global clinical trial-the ENCORE1 study. Ther Drug Monit 39: 654658.
  49. Kothare PA, Bateman KP, Dockendorf M, Stone J, Xu Y, Woolf E, Shipley LA, , 2016. An integrated strategy for implementation of dried blood spots in clinical development programs. AAPS J 18: 519527.
  50. Antunes MV, Charão MF, Linden R, , 2016. Dried blood spots analysis with mass spectrometry: potentials and pitfalls in therapeutic drug monitoring. Clin Biochem 49: 10351046.
  51. Edelbroek PM, van der Heijden J, Stolk LML, , 2009. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther Drug Monit 31: 327336.
  52. Enderle Y, Foerster K, Burhenne J, , 2016. Clinical feasibility of dried blood spots: analytics, validation, and applications. J Pharm Biomed Anal 130: 231243.
  53. Panchal T, Spooner N, Barfield M, , 2017. Ensuring the collection of high-quality dried blood spot samples across multisite clinical studies. Bioanalysis 9: 209213.
  54. Li C-C, 2017. Population PK analyses of Ubrogepant (MK-1602), a CGRP receptor antagonist: enriching in-clinic plasma PK sampling with outpatient dried blood spot sampling. J Clin Pharmacol 58: 294303.
  55. Guerra Valero YC, Wallis SC, Lipman J, Stove C, Roberts JA, Parker SL, , 2018. Clinical application of microsampling versus conventional sampling techniques in the quantitative bioanalysis of antibiotics: a systematic review. Bioanalysis 10: 407423.
  56. Wilhelm AJ, den Burger JCG, Swart EL, , 2014. Therapeutic drug monitoring by dried blood spot: progress to date and future directions. Clin Pharmacokinet 53: 961973.
  57. Muzembo BA, Mbendi NC, Nakayama SF, , 2017. Systematic review with meta-analysis: performance of dried blood spots for hepatitis C antibodies detection. Public Health 153: 128136.
  58. Greenman J, Roberts T, Cohn J, Messac L, , 2015. Dried blood spot in the genotyping, quantification and storage of HCV RNA: a systematic literature review. J Viral Hepat 22: 353361.
  59. Lange B, 2017. Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples—a systematic review and meta-analysis. BMC Infect Dis 17 (Suppl 1): 693.
  60. Villar LM, de Oliveira JC, Cruz HM, Yoshida CFT, Lampe E, Lewis-Ximenez LL, , 2011. Assessment of dried blood spot samples as a simple method for detection of hepatitis B virus markers. J Med Virol 83: 15221529.
  61. Jardi R, Rodriguez-Frias F, Buti M, Schaper M, Valdes A, Martinez M, Esteban R, Guardia J, , 2004. Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA. Hepatology 40: 133139.
  62. Bertagnolio S, Parkin NT, Jordan M, Brooks J, García-Lerma JG, , 2010. Dried blood spots for HIV-1 drug resistance and viral load testing: a review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS Rev 12: 195208.
  63. Hamers RL, Smit PW, Stevens W, Schuurman R, Rinke de Wit TF, , 2009. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir Ther 14: 619629.
  64. Parkin NT, , 2014. Measurement of HIV-1 viral load for drug resistance surveillance using dried blood spots: literature review and modeling of contribution of DNA and RNA. AIDS Rev 16: 160171.
  65. Adawaye C, Kamangu E, Moussa AM, Tchoumbou B, Vaira D, Moutschen M, , 2013. Use of dried blood spot to improve the diagnosis and management of HIV in resource-limited settings. World J AIDS 3: 251256.
  66. Johannessen A, , 2010. Dried blood spots in HIV monitoring:applications in resource-limited settings. Bioanalysis 2: 18931908.
  67. Denniff P, Spooner N, , 2010. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis 2: 13851395.
  68. De Kesel PM, Sadones N, Capiau S, Lambert WE, Stove CP, , 2013. Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions. Bioanalysis 5: 20232041.
  69. Chao TC, Trybala A, Starov V, Das DB, , 2014. Influence of haematocrit level on the kinetics of blood spreading on thin porous medium during dried blood spot sampling. Colloids Surf A Physicochem Eng Asp 451: 3847.
  70. O’Mara M, Hudson-Curtis B, Olson K, Yueh Y, Dunn J, Spooner N, , 2011. The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples. Bioanalysis 3: 23352347.
  71. Hall EM, Flores SR, De Jesús VR, , 2015. Influence of hematocrit and total-spot volume on performance characteristics of dried blood spots for newborn screening. Int J Neonatal Screen 1: 6978.
  72. Lawson AJ, Bernstone L, Hall SK, , 2016. Newborn screening blood spot analysis in the UK: influence of spot size, punch location and haematocrit. J Med Screen 23: 716.
  73. Butler AM, Charoensiriwatana W, Krasao P, Pankanjanato R, Thong-Ngao P, Polson RC, Snow G, Ehrenkranz J, , 2017. Newborn thyroid screening: influence of pre-analytic variables on dried blood spot thyrotropin measurement. Thyroid 27: 11281134.
  74. Fan L, Lee JA, , 2012. Managing the effect of hematocrit on DBS analysis in a regulated environment. Bioanalysis 4: 345347.
  75. den Burger JCG, Wilhelm AJ, Chahbouni AC, Vos RM, Sinjewel A, Swart EL, , 2015. Haematocrit corrected analysis of creatinine in dried blood spots through potassium measurement. Anal Bioanal Chem 407: 621627.
  76. Abu-Rabie P, Denniff P, Spooner N, Chowdhry BZ, Pullen FS, , 2015. Investigation of different approaches to incorporating internal standard in DBS quantitative bioanalytical workflows and their effect on nullifying hematocrit-based assay bias. Anal Chem 87: 49965003.
  77. Spooner N, Olatunji A, Webbley K, , 2018. Investigation of the effect of blood hematocrit and lipid content on the blood volume deposited by a disposable dried blood spot collection device. J Pharm Biomed Anal 149: 419424.
  78. Polley SD, Bell D, Oliver J, Tully F, Perkins MD, Chiodini PL, González IJ, , 2015. The design and evaluation of a shaped filter collection device to sample and store defined volume dried blood spots from finger pricks. Malar J 14: 45.
  79. Fang K, Bowen CL, Kellie JF, Karlinsey MZ, Evans CA, , 2018. Drug monitoring by volumetric absorptive microsampling: method development considerations to mitigate hematocrit effects. Bioanalysis 10: 241255.
  80. Aylward LL, Hays SM, Smolders R, Koch HM, Cocker J, Jones K, Warren N, Levy L, Bevan R, , 2014. Sources of variability in biomarker concentrations. J Toxicol Environ Health B Crit Rev 17: 4561.
  81. Tang R, 2017. Capillary blood for point-of-care testing. Crit Rev Clin Lab Sci 54: 294308.
  82. Kupke IR, Kather B, Zeugner S, , 1981. On the composition of capillary and venous blood serum. Clin Chim Acta 112: 177185.
  83. Canier L, 2015. Malaria PCR detection in Cambodian low-transmission settings: dried blood spots versus venous blood samples. Am J Trop Med Hyg 92: 573577.
  84. Bond MM, Richards-Kortum RR, , 2015. Drop-to-drop variation in the cellular components of fingerprick blood: implications for point-of-care diagnostic development. Am J Clin Pathol 144: 885894.
  85. Morris SS, Ruel MT, Cohen RJ, Dewey KG, de la Brière B, Hassan MN, , 1999. Precision, accuracy, and reliability of hemoglobin assessment with use of capillary blood. Am J Clin Nutr 69: 12431248.
  86. Kayiran SM, Ozbek N, Turan M, Gürakan B, , 2003. Significant differences between capillary and venous complete blood counts in the neonatal period. Clin Lab Haematol 25: 916.
  87. Zanet DL, Saberi S, Oliveira L, Sattha B, Gadawski I, Côté HCF, , 2013. Blood and dried blood spot telomere length measurement by qPCR: assay considerations. PLoS One 8: e57787.
  88. Emmons G, Rowland M, , 2010. Pharmacokinetic considerations as to when to use dried blood spot sampling. Bioanalysis 2: 17911796.
  89. Chen X, Zhao H, Hatsis P, Amin J, , 2012. Investigation of dried blood spot card-induced interferences in liquid chromatography/mass spectrometry. J Pharm Biomed Anal 61: 3037.
  90. Matuszewski BK, Constanzer ML, Chavez-Eng CM, , 2003. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75: 30193030.
  91. Li W, Tse FLS, , 2010. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed Chromatogr 24: 4965.
  92. Ren X, Paehler T, Zimmer M, Guo Z, Zane P, Emmons GT, , 2010. Impact of various factors on radioactivity distribution in different DBS papers. Bioanalysis 2: 14691475.
  93. Lenk G, Hansson J, Beck O, Roxhed N, , 2015. The effect of drying on the homogeneity of DBS. Bioanalysis 7: 19771985.
  94. Koster RA, Botma R, Greijdanus B, Uges DRA, Kosterink JGW, Touw DJ, Alffenaar J-WC, , 2015. The performance of five different dried blood spot cards for the analysis of six immunosuppressants. Bioanalysis 7: 12251235.
  95. Rottinghaus EK, Beard RS, Bile E, Modukanele M, Maruping M, Mine M, Nkengasong J, Yang C, , 2014. Evaluation of dried blood spots collected on filter papers from three manufacturers stored at ambient temperature for application in HIV-1 drug resistance monitoring. PLoS One 9: e109060.
  96. Rottinghaus E, Bile E, Modukanele M, Maruping M, Mine M, Nkengasong J, Yang C, , 2013. Comparison of Ahlstrom grade 226, Munktell TFN, and Whatman 903 filter papers for dried blood spot specimen collection and subsequent HIV-1 load and drug resistance genotyping analysis. J Clin Microbiol 51: 5560.
  97. Levine M, Beck I, Styrchak S, Pepper G, Frenkel L, , 2016. Comparison of matrix-based and filter paper-based systems for transport of plasma for HIV-1 RNA quantification and amplicon preparation for genotyping. J Clin Microbiol 54: 18991901.
  98. Schlusser KE, 2017. Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma. PLoS One 12: e0172283.
  99. Gibson LE, Markwalter CF, Kimmel DW, Mudenda L, Mbambara S, Thuma PE, Wright DW, , 2017. Plasmodium falciparum HRP2 ELISA for analysis of dried blood spot samples in rural Zambia. Malar J 16: 350.
  100. Jones S, 2012. Filter paper collection of Plasmodium falciparum mRNA for detecting low-density gametocytes. Malar J 11: 266.
  101. Mlambo G, Vasquez Y, LeBlanc R, Sullivan D, Kumar N, , 2008. A filter paper method for the detection of Plasmodium falciparum gametocytes by reverse transcription polymerase chain reaction. Am J Trop Med Hyg 78: 114116.
  102. Miguel RB, Coura JR, Samudio F, Suárez-Mutis MC, , 2013. Evaluation of three different DNA extraction methods from blood samples collected in dried filter paper in Plasmodium subpatent infections from the Amazon region in Brazil. Rev Inst Med Trop São Paulo 55: pii: S0036-46652013000300205.
  103. Bereczky S, Mårtensson A, Gil JP, Färnert A, , 2005. Short report: rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparum. Am J Trop Med Hyg 72: 249251.
  104. Zhong KJ, Salas CJ, Shafer R, Gubanov A, Gasser RA, Magill AJ, Forney JR, Kain KC, , 2001. Comparison of IsoCode STIX and FTA gene guard collection matrices as whole-blood storage and processing devices for diagnosis of malaria by PCR. J Clin Microbiol 39: 11951196.
  105. Zainabadi K, Adams M, Han ZY, Lwin HW, Han KT, Ouattara A, Thura S, Plowe CV, Nyunt MM, , 2017. A novel method for extracting nucleic acids from dried blood spots for ultrasensitive detection of low-density Plasmodium falciparum and Plasmodium vivax infections. Malar J 16: 377.
  106. Bowen CL, Dopson W, Kemp DC, Lewis M, Lad R, Overvold C, , 2011. Investigations into the environmental conditions experienced during ambient sample transport: impact to dried blood spot sample shipments. Bioanalysis 3: 16251633.
  107. Denniff P, Spooner N, , 2010. Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates. Bioanalysis 2: 18171822.
  108. Adam BW, Haynes CA, Chafin DL, De Jesus VR, , 2014. Stabilities of intact hemoglobin molecules and hemoglobin peptides in dried blood samples. Clin Chim Acta 429: 5960.
  109. Björkesten J, 2017. Stability of proteins in dried blood spot Biobanks. Mol Cell Proteomics 16: 12861296.
  110. Kyle JE, 2017. Comparing identified and statistically significant lipids and polar metabolites in 15-year old serum and dried blood spot samples for longitudinal studies. Rapid Commun Mass Spectrom 31: 447456.
  111. Adam BW, Chafin DL, De Jesús VR, , 2013. Stabilities of hemoglobins A and S in dried blood spots stored under controlled conditions. Clin Biochem 46: 10891092.
  112. Lin Y-Q, Zhang Y, Li C, Li L, Zhang K, Li S, , 2012. Evaluation of dry blood spot technique for quantification of an anti-CD20 monoclonal antibody drug in human blood samples. J Pharmacol Toxicol Methods 65: 4448.
  113. Mei JV, Alexander JR, Adam BW, Hannon WH, , 2001. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 131: 1631S1636S.
  114. Adam BW, Hall EM, Sternberg M, Lim TH, Flores SR, O’Brien S, Simms D, Li LX, De Jesus VR, Hannon WH, , 2011. The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States. Clin Biochem 44: 14451450.
  115. Han J, Higgins R, Lim MD, Lin K, Yang J, Borchers CH, , 2017. Short-term stabilities of 21 amino acids in dried blood spots. Clin Chem 64: 400402.
  116. Golbahar J, Altayab DD, Carreon E, , 2014. Short-term stability of amino acids and acylcarnitines in the dried blood spots used to screen newborns for metabolic disorders. J Med Screen 21: 59.
  117. Grauholm J, Khoo SK, Nickolov RZ, Poulsen JB, Bækvad-Hansen M, Hansen CS, Hougaard DM, Hollegaard MV, , 2015. Gene expression profiling of archived dried blood spot samples from the Danish Neonatal Screening Biobank. Mol Genet Metab 116: 119124.
  118. Ho NT, Busik JV, Resau JH, Paneth N, Khoo SK, , 2016. Effect of storage time on gene expression data acquired from unfrozen archived newborn blood spots. Mol Genet Metab 119: 207213.
  119. Pupillo D, Simonato M, Cogo PE, Lapillonne A, Carnielli VP, , 2016. Short-term stability of whole blood polyunsaturated fatty acid content on filter paper during storage at −28 °C. Lipids 51: 193198.
  120. Supriya M, De T, Christopher R, , 2018. Effect of temperature on lysosomal enzyme activity during preparation and storage of dried blood spots. J Clin Lab Anal 32: e22220.
  121. Elbin CS, Olivova P, Marashio CA, Cooper SK, Cullen E, Keutzer JM, Zhang XK, , 2011. The effect of preparation, storage and shipping of dried blood spots on the activity of five lysosomal enzymes. Clin Chim Acta 412: 12071212.
  122. Adam BW, Orsini JJ, Martin M, Hall EM, Zobel SD, Caggana M, Hannon WH, , 2011. The preparation and storage of dried-blood spot quality control materials for lysosomal storage disease screening tests. Clin Biochem 44: 704710.
  123. De Jesus VR, Zhang XK, Keutzer J, Bodamer OA, Mühl A, Orsini JJ, Caggana M, Vogt RF, Hannon WH, , 2009. Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders. Clin Chem 55: 158164.
  124. Flores SR, Hall EM, De Jesús VR, , 2017. Glucose-6-phosphate dehydrogenase enzyme stability in filter paper dried blood spots. Clin Biochem 50: 878881.
  125. Jalil N, Azma RZ, Mohamed E, Ithnin A, Alauddin H, Baya SN, Othman A, , 2016. Evaluation of glucose-6-phosphate dehydrogenase stability in stored blood samples. EXCLI J 15: 155162.
  126. McAllister G, Shepherd S, Templeton K, Aitken C, Gunson R, , 2015. Long term stability of HBsAg, anti-HBc and anti-HCV in dried blood spot samples and eluates. J Clin Virol 71: 1017.
  127. Ndiaye O, 2017. Usefulness of dried blood spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal. J Med Virol 89: 484488.
  128. Parr JB, 2018. An efficient, large-scale survey of hepatitis C viremia in the Democratic Republic of the Congo using dried blood spots. Clin Infect Dis 66: 254260.
  129. Tejada-Strop A, Drobeniuc J, Mixson-Hayden T, Forbi JC, Le N-T, Li L, Mei J, Terrault N, Kamili S, , 2015. Disparate detection outcomes for anti-HCV IgG and HCV RNA in dried blood spots. J Virol Methods 212: 6670.
  130. Marques BL, Brandão CU, Silva EF, Marques VA, Villela-Nogueira CA, Do Ó KM, de Paula MT, Lewis-Ximenez LL, Lampe E, Villar LM, , 2012. Dried blood spot samples: optimization of commercial EIAs for hepatitis C antibody detection and stability under different storage conditions. J Med Virol 84: 16001607.
  131. Dauner AL, Gilliland TC, Mitra I, Pal S, Morrison AC, Hontz RD, Wu S-JL, , 2015. Evaluation of nucleic acid stabilization products for ambient temperature shipping and storage of viral RNA and antibody in a dried whole blood format. Am J Trop Med Hyg 93: 4653.
  132. Ruangturakit S, Rojanasuphot S, Srijuggravanvong A, Duangchanda S, Nuangplee S, Igarashi A, , 1994. Storage stability of dengue IgM and IgG antibodies in whole blood and serum dried on filter paper strips detected by ELISA. Southeast Asian J Trop Med Public Health 25: 560564.
  133. Schwartz A, Baidjoe A, Rosenthal PJ, Dorsey G, Bousema T, Greenhouse B, , 2015. The effect of storage and extraction methods on amplification of Plasmodium falciparum DNA from dried blood spots. Am J Trop Med Hyg 92: 922925.
  134. Strøm GEA, Moyo S, Fataki M, Langeland N, Blomberg B, , 2014. PCR targeting Plasmodium mitochondrial genome of DNA extracted from dried blood on filter paper compared to whole blood. Malar J 13: 137.
  135. Chaorattanakawee S, Natalang O, Hananantachai H, Nacher M, Brockman A, Krudsood S, Looareesuwan S, Patarapotikul J, , 2003. Storage duration and polymerase chain reaction detection of Plasmodium falciparum from blood spots on filter paper. Am J Trop Med Hyg 69: 4244.
  136. Hwang J, Jaroensuk J, Leimanis ML, Russell B, McGready R, Day N, Snounou G, Nosten F, Imwong M, , 2012. Long-term storage limits PCR-based analyses of malaria parasites in archival dried blood spots. Malar J 11: 339.
  137. Strøm GEA, Tellevik MG, Hanevik K, Langeland N, Blomberg B, , 2014. Comparison of four methods for extracting DNA from dried blood on filter paper for PCR targeting the mitochondrial Plasmodium genome. Trans R Soc Trop Med Hyg 108: 488494.
  138. Pritsch M, Wieser A, Soederstroem V, Poluda D, Eshetu T, Hoelscher M, Schubert S, Shock J, Loescher T, Berens-Riha N, , 2012. Stability of gametocyte-specific Pfs25-mRNA in dried blood spots on filter paper subjected to different storage conditions. Malar J 11: 138.
  139. Corran PH, 2008. Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J 7: 195.
  140. García-Lerma JG, McNulty A, Jennings C, Huang D, Heneine W, Bremer JW, , 2009. Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37 degrees C and high humidity. J Antimicrob Chemother 64: 3336.
  141. Youngpairoj AS, Masciotra S, Garrido C, Zahonero N, de Mendoza C, García-Lerma JG, , 2008. HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees C. J Antimicrob Chemother 61: 12171220.
  142. Aitken SC, Wallis CL, Stevens W, de Wit TR, Schuurman R, , 2015. Stability of HIV-1 nucleic acids in dried blood spot samples for HIV-1 drug resistance genotyping. PLoS One 10: e0131541.
  143. Parry CM, 2014. Field study of dried blood spot specimens for HIV-1 drug resistance genotyping. J Clin Microbiol 52: 28682875.
  144. Mitchell C, et al.; Dried Blood Spot Working Group of the Infant Maternal Pediatric Adolescent AIDS Clinical Trials Network, 2008. Diminished human immunodeficiency virus type 1 DNA yield from dried blood spots after storage in a humid incubator at 37 degrees C compared to −20 degrees C. J Clin Microbiol 46: 29452949.
  145. Monleau M, Butel C, Delaporte E, Boillot F, Peeters M, , 2010. Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping. J Antimicrob Chemother 65: 15621566.
  146. Amellal B, Katlama C, Calvez V, , 2007. Evaluation of the use of dried spots and of different storage conditions of plasma for HIV-1 RNA quantification. HIV Med 8: 396400.
  147. Wei X, Smith AJ, Forrest DW, Cardenas GA, Beck DW, LaLota M, Metsch LR, Sionean C, Owen SM, Johnson JA, , 2016. Incident infection and resistance mutation analysis of dried blood spots collected in a field study of HIV risk groups, 2007–2010. PLoS One 11: e0159266.
  148. Begley CG, Ellis LM, , 2012. Raise standards for preclinical cancer research. Nature 483: 531533.
  149. Luckwell J, 2013. Assessment of the within- and between-lot variability of Whatman™ FTA(®) DMPK and 903(®) DBS papers and their suitability for the quantitative bioanalysis of small molecules. Bioanalysis 5: 26132630.
  150. Matheus S, de Laval F, Moua D, N’Guyen C, Martinez E, Rousset D, Briolant S, , 2017. Zika virus persistence and higher viral loads in cutaneous capillaries than in venous blood. Emerg Infect Dis 23: 19101911.
  151. Boghani S, Mei Z, Perry GS, Brittenham GM, Cogswell ME, , 2017. Accuracy of capillary hemoglobin measurements for the detection of anemia among U.S. low-income toddlers and pregnant women. Nutrients 9: pii: E253.
  152. Daae LN, Halvorsen S, Mathisen PM, Mironska K, , 1988. A comparison between haematological parameters in “capillary” and venous blood from healthy adults. Scand J Clin Lab Invest 48: 723726.
  153. Bancone G, Chu CS, Chowwiwat N, Somsakchaicharoen R, Wilaisrisak P, Charunwatthana P, Bansil P, McGray S, Domingo GJ, Nosten FH, , 2015. Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests. Am J Trop Med Hyg 92: 818824.
  154. Kocisko DA, Walsh DS, Eamsila C, Edstein MD, , 2000. Measurement of tafenoquine (WR 238605) in human plasma and venous and capillary blood by high-pressure liquid chromatography. Ther Drug Monit 22: 184189.
  155. Ashley EA, Stepniewska K, Lindegardh N, Annerberg A, Tarning J, McGready R, Phaiphun L, Singhasivanon P, White NJ, Nosten F, , 2010. Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria. Eur J Clin Pharmacol 66: 705712.
  156. Diaw PA, Daneau G, Coly AA, Ndiaye BP, Wade D, Camara M, Mboup S, Kestens L, Dieye TN, , 2011. Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4. J Acquir Immune Defic Syndr 58: e103e111.
  157. Steinmetzer K, Seidel T, Stallmach A, Ermantraut E, , 2010. HIV load testing with small samples of whole blood. J Clin Microbiol 48: 27862792.
  158. Bruns T, Steinmetzer K, Ermantraut E, Stallmach A, , 2009. Hepatitis C virus RNA quantitation in venous and capillary small-volume whole-blood samples. J Clin Microbiol 47: 32313240.
  159. Descloux E, La Fuentez C, Roca Y, De Lamballerie X, , 2014. Clinical significance of intra-host variability of dengue-1 virus in venous and capillary blood. Clin Microbiol Infect 20: O167O175.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.17-0889
Loading
/content/journals/10.4269/ajtmh.17-0889
Loading

Data & Media loading...

  • Received : 15 Nov 2017
  • Accepted : 02 May 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error